Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
FOSTER CITY, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing medicines to address difficult-to-treat cancers, today announced that Guo-Liang Yu, Ph.D., Chairman and Chief Executive Officer of Apollomics, and Sanjeev Redkar, Ph.D., President of Apollomics, will participate in a Fireside Chat at the B. Riley Securities 2024 Virtual Oncology Conference on Thursday, January 18, 2024 at 11:00 a.m. ET.
Related news for (APLM)
- Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
- 24/7 Market News Snapshot 31 March, 2025 – Apollomics Inc. Class A Ordinary Shares (NASDAQ:APLM)
- Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
- Apollomics and LaunXP Team Up to Supercharge Vebreltinib in Asia’s NSCLC Fight
- Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia